Clinical Trial Update: A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial of cotadutide in participants with type 2 diabetes mellitus and chronic kidney disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Cotadutide (cotadutide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases | Phase 2 | Status: COMPLETED | Results posted: 2025-01-17